GSK Gsk Plc

TIDMGSK

RNS Number : 3595J

GlaxoSmithKline PLC

26 April 2022

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
1.   Details of PDMR/person closely associated with them 
      ('PCA') 
a)   Name                                    Dr H Barron 
b)   Position/status                         Chief Scientific Officer and President, 
                                              R&D 
c)   Initial notification/                   Initial notification 
      amendment 
2.   Details of the issuer, emission allowance market participant, 
      auction platform, auctioneer or auction monitor 
a)   Name                                    GlaxoSmithKline plc 
b)   LEI                                     5493000HZTVUYLO1D793 
3.   Details of the transaction(s): section to be repeated 
      for (i) each type of instrument; (ii) each type of transaction; 
      (iii) each date; and (iv) each place where transaction(s) 
      has been conducted 
a)   Description of                          American Depositary Shares ('ADSs') 
      the financial 
      instrument                              ISIN: US37733W1053 
b)   Nature of the                           Acquisition of notional ADSs within Dr 
      transaction                             Barron's GSK Executive Supplemental Savings 
                                              Plan account. 
c)   Price(s) and                             Price(s)                Volume(s) 
      volume(s) 
                                              $44.8700                1,147.942 
 
d)   Aggregated information                  N/A (single transaction) 
 Aggregated volume 
  Price 
e)   Date of the transaction                 2022-04-22 
f)   Place of the                            New York Stock Exchange (XNYS) 
      transaction 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHVQLBLLZLLBBV

(END) Dow Jones Newswires

April 26, 2022 12:37 ET (16:37 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024

Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024